Parkinson plus pp 18-31 | Cite as
Klinische Neuropathologie des Parkinson-Syndroms — Proteintyp und Dopamintyp der Demelaninisierung
Chapter
Zusammenfassung
Die neuronale Zytopathologie des Parkinsonismus interessiert ätiopathogenetisch besonders im Hinblick auf morphologisch-biochemische Strukturbeziehungen. Demgegenüber ist ihre zentralnervöse Topologie für die klinisch-neurologische Symptombildung von Bedeutung.
Preview
Unable to display preview. Download preview PDF.
Literatur
- Agnoli A (1980) Aging and extrapyramidal Syndromes (Parkinsonism). In: Barbagallo-Sangiorg G (ed) The aging brain, Vol 5. Plenum Press, New York LondonGoogle Scholar
- Alvord ED, Forno L, Kusske JA, Kaufmann RJ (1974) The pathology of parkinsonism. A comparison of degeneration in cerebral cortex and brain System. Adv Neurol 5:175–193PubMedGoogle Scholar
- AndrÉ JM, Royer RJ, Due M, Kissel P (1974) Analyse d’un échec thérapeutique de la L-Dopa. Rev Neurol 130:322–326PubMedGoogle Scholar
- Andrews JM, Terry RD, Spataro J (1970) Arch Neurol 23:319–329PubMedGoogle Scholar
- Bagh K von (1946) Über anatomische Befunde bei 30 Fällen von systematischer Atrophie der Großhirnrinde. Ann Acad Sci Fenn A 5/10:1–132Google Scholar
- Bazelon M, Fenichel GM, Ino Randall BA (1967) Studies in neuromelanin. I: A melanin System in human adult brainstem. Neurology 17/1:512–519Google Scholar
- Bethlem J, den Hartog Jager NA (1960) The incidence and characteristics of Lewy-bodies in idiopathic paralysis agitans. J Neurol Neurosurg Psychiatry 23:74–80PubMedCrossRefGoogle Scholar
- Duffy PF, Tennyson VM (1965) Phase and electron microscopic observations of the Lewy-bodies and melanin-granules in the substantia nigra and locus coeruleus in Parkinson’s disease. J Neuropathol Exp Neurol 24:398–414CrossRefGoogle Scholar
- Fahn S (1976) Biochemistry of the basal ganglia. Adv Neurol 14:59–89PubMedGoogle Scholar
- Fahn S (1977) Parkinson’s Disease In: Goldensohn ES, Appel S (eds). Scientific (Appr.) to clinical Neurology. Lea & Febiger, Philadelphia, pp 1119–1158Google Scholar
- Fahn S, Duffy P (1977) The role of bromocriptin in the treatment of Parkinsonism. Neurology 29:1077–1083Google Scholar
- Feve JR, Mussini JM, MathÉ JF, Cler JM, Nomballais MF (1977) Dégénérescence striato-nigrique. Rev Neurol 133/4:271–278Google Scholar
- Fischer P-A, Jacobi P, Schneider E, Becker H (1976) Correlation between clinical and CT-fmdings in Parkinson’s Syndrome. In: Lanksch N, Kazner E (eds) Computerized tomography. Springer, Berlin Heidelberg New York, pp 244–248Google Scholar
- FoIx C, Nicolesco J (1925) Les noyaux gris centraux et la région mésencephalo-sous-thalamique. Masson, ParisGoogle Scholar
- Foley JM, Baxter D (1958) On the nature of pigment granules in the cells of the locus coeruleus and substantia nigra. J Neuropathol Exp Neurol 17:586–589PubMedCrossRefGoogle Scholar
- Forno LS (1971) The pathology of Parkinsonism. In: Dowell FH, Markham CH (eds) Rec. Advanc in Parkinson’s disease. Davis Philadelphia, pp 119–161Google Scholar
- Forno LS (1974) Depigmentation in the nerve cells of the substantia nigra and locus coeruleus in Parkinsonism. Adv Neurol 5:195–202PubMedGoogle Scholar
- Forno LS, Strefling AM, Sternberger LA, Sternberger NH, Eng LF (1983) Immunocytochemical staining of neurofibrillary tangles and of the periphery of lewy bodies with a monoclonal antibody to neurofilaments. Am Assoc Neuropathol-Abstracts of the 59. Annual Meeting, St. Louis N 111Google Scholar
- Gambetti P, Shecket G, Ghetti B, Hirano A, Dahl P (1983) Neurofibrillary changes in human brain. J Neuropathol Exp Neurol 42/1:69–79CrossRefGoogle Scholar
- Gellerstedt F (1933) Zur Kenntnis der Hirnveränderungen bei der normalen Altersinvolution. Inaug.-Diss. UppsallaGoogle Scholar
- Goldman JE, Yen SH, Chiu FC, Pereos NS (1983) Neurofilament antibodies react with Lewy bodies. Am Assoc Neuropathol-Abstracts of the 59th Annual Meeting St. Louis N 86Google Scholar
- Hassler R (1937) Zur Normalanatomie des Substantia nigra. J Psychol Neurol 48/1:1–55Google Scholar
- Ikeda K, Ikeda S, Yoshimura T, Kato H, Namba M (1978) Idiopathic Parkinsonism with Lewy-typ inclusions in cerebral cortex. Acta Neuropathol 41:165–168PubMedCrossRefGoogle Scholar
- Jacob H (1960) Differentialdiagnose perniciöser Involutionspsychosen, präseniler Psychosen und Psychosen bei Involutionspellagra. Arch Psychiatr Nervenkr 201:17–52CrossRefGoogle Scholar
- Jacob H (1967) Zur klinisch-neuropathologischen Differentialdiagnose präsenil-involutiver Erkrankungen des Zentralnervensystems. Acta Neuropathol (Suppl) 3:110–118Google Scholar
- Jacob H (1971) Extrapyramidal-pyramidal-akinetische Syndrome bei progressiven Encephalopathien mit achromatischen Nervenzellschwellungen und Zellgliosen im höheren Lebensalter. Acta Neuropathol 17:341–352PubMedCrossRefGoogle Scholar
- Jacob H (1978) Neuropathologie des Parkinson-Syndroms und die Senescenz des Gehirns. In: Fischer PA (Hrsg) Langzeitbehandlung des Parkinson-Syndroms. Schattauer, Stuttgart New YorkGoogle Scholar
- Jacob H (1982a) Neuropathologie des Parkinson-Syndroms und Seneszenz des Gehirns. In: Pfeiffer EF (Hrsg) Bromocriptin. Ein fachübergreifendes Therapieprinzip. 8. Rothenburger Gespräch 21./22. Mai 1981. Schattauer, Stuttgart New York S 87–98Google Scholar
- Jacob H (1982 b) Lokalisation neuropathologischer Prozesse und klinische Symptomatik. Neuropa-thologica (Jpn) 3:77–94Google Scholar
- Jacob H (1983) Klinische Neuropathologie des Parkinsonismus. 13. Zentraleuropäisches Symposion, Heidelberg. Roche, BaselGoogle Scholar
- Jellinger K (1974) Pathomorphologie des Parkinson-Syndroms. Aktuel Neurol 1:83–98Google Scholar
- Kaiya H, Yoshimura T, Namba M (1977) Cortico-cerebello-thalamic degeneration with chromatolytic neuronal swelling. Folia Psychiatr Neurol (Jpn) 5:292–311Google Scholar
- Kosaka K, Oyanagi S, Matsushita M, Hori A, Iwase S (1976) Presenile dementia with Alzheimer-,Pick-and Lewy-bodies. Acta Neuropathol 36:221–233PubMedCrossRefGoogle Scholar
- Kosaka K, Mehraein P (1979) Dementia-Parkinsonism-syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch Psychiatr Nervenkr 226:241–250PubMedCrossRefGoogle Scholar
- Kosaka K, Matsushita M, Oyanagi S, Mehraein P (1982 a) A clinico neuropathological study in Lewy-bodies disease. Psychiatr Neurol (Jpn) 5:292–311Google Scholar
- Kosaka K, Yoshimura M, Ikeda K, Seitelberger F (1982 b) Diffuse Type of Lewy-body disease. IX. Int. Congr. of Neuropathology, WienGoogle Scholar
- Lust WD, Mrsulja BB, Passoneau JV, Klatzo I (1975) Putative neurotransmitters and cyclic nucleotides in prolonged ischemia of the cerebral cortex. Brain Res 98:349–399CrossRefGoogle Scholar
- Maeda S, Yokoi S, Isaka K (1973) An unusual type of familial extrapyramidal disease: Cortico-striato-pallido-nigral degeneration. Psychiatr Neurol (Jpn) 75:657–672Google Scholar
- Mann DMA, Yates PO, Barton CM (1977) Neuromelanin and RNA in cells of the substantia nigra. J Neuropathol Exp Neurol 36:379–383PubMedCrossRefGoogle Scholar
- Mann DMA, Yates PO (1979) Effects of ageing in the pigmented nerve cells of the human locus coeruleus and substantia nigra. Acta Neuropathol 47:93–97PubMedCrossRefGoogle Scholar
- Mann DMA, Yates PO (1982) Pathogenesis of Parkinson’s disease. Arch Neurol 39:545–549PubMedGoogle Scholar
- McGeer EC, McGeer PL, Suzuki JS (1977) Ageing and extrapyramidal function. Arch Neurol 34:33–35PubMedGoogle Scholar
- Michel D, Tommasi M, Laurent B, Trillet M, Schott B (1976) Dégénérescence striato-nigrique. Rev Neurol 132:3–22PubMedGoogle Scholar
- Rajput AH (1972) Striato-nigral degeneration-Response to levodopa therapy. J Neurol Sci 16:331–341PubMedCrossRefGoogle Scholar
- Riederer P, Jellinger K (1980) Zur Bedeutung der Senescenz zerebraler Neurotransmitter für das Parkinson-Syndrom. In: Fischer PA (Hrsg) Parkinson-Syndrom: Kombinations-und Begleittherapien. Schattauer, Stuttgart New YorkGoogle Scholar
- Rebeiz JJ, Kolodny EH, Richardson E (1968) Cortico-dentato-nigral degeneration with neuronal achromasia. Arch Neurol (Chic) 18:20–33Google Scholar
- Schneider E, Fischer P-A, Becker H, Hacker H, Pencz A, Jacobi P (1977) Relationship between arteriosclerotic and cerebral atrophy in Parkinson’s disease. Neurology 217:11–16CrossRefGoogle Scholar
- Schneider E, Fischer P-A, Jacobi P, Becker H (1978) Zur Relevanz extranigraler Hirnläsionen bei Parkinson-Kranken. In: Fischer P-A (Hrsg) Langzeitbehandlung des Parkinson-Syndroms. Schattauer, Stuttgart New YorkGoogle Scholar
- Seitelberger F (1975) Achromatic neuronal dystrophy. VII. Internat Congr. of Neuropathol. 1974, Vol I. Excerpta Medica, AmsterdamGoogle Scholar
- Sharpe JA, Rewcastle NB, Lloyd KG, Hornykiewicz O, Hill M, Tasker RR (1973) Striato-nigral degeneration. J Neurolog Sci 19:275–286CrossRefGoogle Scholar
- TakÁts A (1982) Neuropathological examination of 57 Parkinson patients. IX. Int. Congr. of Neuro-pathology, Wien, p 115Google Scholar
- Tomonaga M (1981) Neuroflbrillary tangles and Lewy-bodies in the locus coeruleus of the aged brain. Acta Neuropathol 53:165PubMedCrossRefGoogle Scholar
- Williams HW (1935) The peculiar cells of Pick’s disease. Arch Neurol 34:508–519Google Scholar
- Woodard JS (1962) Concentric hyaline inclusion body formation in mental disease analysis of 27 cases. J Neuronath Exp Neurol 21/3: 442–449CrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin-Heidelberg 1984